Imunon, Inc. (IMNN)
NASDAQ: IMNN · Real-Time Price · USD
0.9000
+0.0299 (3.44%)
At close: Nov 3, 2026, 4:00 PM EST
0.9130
+0.0130 (1.44%)
After-hours: Nov 3, 2026, 5:45 PM EST
Imunon Employees
Imunon had 20 employees as of December 31, 2025. The number of employees decreased by 5 or 20.00% compared to the previous year. That makes Imunon the 38,327th largest employer in the world and 5,529th in the United States.
Employees
20
Change (1Y)
-5
Growth (1Y)
-20.00%
Revenue / Employee
n/a
Profits / Employee
-$736,658
Market Cap
5.05M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 20 | -5 | -20.00% |
| Dec 31, 2024 | 25 | -8 | -24.24% |
| Dec 31, 2023 | 33 | 2 | 6.45% |
| Dec 31, 2022 | 31 | 2 | 6.90% |
| Dec 31, 2021 | 29 | 2 | 7.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| Longeveron | 38 |
| AIM ImmunoTech | 21 |
| Cardio Diagnostics Holdings | 17 |
| Azitra | 13 |
| Traws Pharma | 7 |
| Can-Fite BioPharma | 5 |
| Xenetic Biosciences | 2 |
IMNN News
- 1 day ago - IMUNON to Hold Third Quarter 2026 Financial Results and Business Update Conference Call on Thursday, November 12, 2026 - GlobeNewsWire
- 6 days ago - Imunon Registration statement: Registration filing - Filings
- 7 days ago - Imunon Registration statement: Registration filing - Filings
- 7 days ago - Imunon files to sell 20M shares of common stock, pre-funded warrants - TheFly
- 13 days ago - Imunon to sell ThermoDox rights to VoxelDox Therapeutics for ownership stake - TheFly
- 13 days ago - IMUNON Announces Strategic Sale of ThermoDox® - GlobeNewsWire
- 26 days ago - IMUNON to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - IMUNON Converts $1.2 Million of Debt-to-Equity - GlobeNewsWire